Squarepoint Portfolio holdings
AUM
$47B
1-Year Est. Return
6.94%
1 Year Est. Return
+6.94%
AUM
$45.5B
AUM Growth
+$4.5B
(+11%)
Holding
3,358
Top Buys
| 1 | +$454M | |
| 2 | +$333M | |
| 3 | +$293M | |
| 4 |
Costco
COST
|
+$290M |
| 5 |
Ford
F
|
+$274M |
Top Sells
| 1 | +$1.7B | |
| 2 | +$374M | |
| 3 | +$193M | |
| 4 |
Fair Isaac
FICO
|
+$191M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$190M |
Sector Composition
| 1 | Technology | 22.48% |
| 2 | Consumer Discretionary | 14.95% |
| 3 | Financials | 10.21% |
| 4 | Healthcare | 10.13% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Vanguard Value ETF
VTV
$156B
| $827K | ﹤0.01% |
+4,678
|
|
||
1627
Haleon
HLN
$43.7B
| $824K | ﹤0.01% |
79,468
-83,390
|
|
||
1628
RadNet
RDNT
$5.5B
| $820K | ﹤0.01% |
14,405
-7,075
|
|
||
1629
First Financial Bancorp
FFBC
$2.62B
| $817K | ﹤0.01% |
33,666
+22,748
|
|
||
1630
Limoneira
LMNR
$273M
| $815K | ﹤0.01% |
52,108
+18,005
|
|
||
1631
LendingClub
LC
$2.19B
| $814K | ﹤0.01% |
67,680
+15,898
|
|
||
1632
Iron Mountain
IRM
$23.5B
| $814K | ﹤0.01% |
7,934
-57,780
|
|
||
1633
Mitek Systems
MITK
$462M
| $814K | ﹤0.01% |
+82,193
|
|
||
1634
Phibro Animal Health
PAHC
$1.64B
| $813K | ﹤0.01% |
+31,844
|
|
||
1635
Nova
NVMI
$9.44B
| $813K | ﹤0.01% |
2,954
-3,296
|
|
||
1636
Transcat
TRNS
$563M
| $812K | ﹤0.01% |
9,452
+6,362
|
|
||
1637
Abeona Therapeutics
ABEO
$271M
| $806K | ﹤0.01% |
141,978
+104,037
|
|
||
1638
Home Bancorp
HBCP
$476M
| $806K | ﹤0.01% |
+15,557
|
|
||
1639
Monte Rosa Therapeutics
GLUE
$1.09B
| $803K | ﹤0.01% |
+178,136
|
|
||
1640
Capitol Federal Financial
CFFN
$918M
| $803K | ﹤0.01% |
131,625
+932
|
|
||
1641
Bridgewater Bancshares
BWB
$513M
| $802K | ﹤0.01% |
50,396
+32,398
|
|
||
1642
Navient
NAVI
$1.27B
| $800K | ﹤0.01% |
56,744
+5,087
|
|
||
1643
LoveSac
LOVE
$201M
| $799K | ﹤0.01% |
43,923
-27,556
|
|
||
1644
Alnylam Pharmaceuticals
ALNY
$51.7B
| $798K | ﹤0.01% |
2,446
-3,822
|
|
||
1645
DTE Energy
DTE
$26.7B
| $794K | ﹤0.01% |
5,995
+16
|
|
||
1646
Omnicell
OMCL
$2.05B
| $792K | ﹤0.01% |
26,924
-134,174
|
|
||
1647
Ambev
ABEV
$39.3B
| $791K | ﹤0.01% |
328,262
+262,941
|
|
||
1648
Ultragenyx Pharmaceutical
RARE
$3.2B
| $788K | ﹤0.01% |
21,683
-198,201
|
|
||
1649
Myriad Genetics
MYGN
$641M
| $788K | ﹤0.01% |
148,335
+68,208
|
|
||
1650
WesBanco
WSBC
$3.33B
| $787K | ﹤0.01% |
24,871
-37,927
|
|